Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vertex Pharmaceuticals
(NQ:
VRTX
)
445.21
+4.57 (+1.04%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Vertex Pharmaceuticals
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
42
43
Next >
Rocket Pharmaceuticals Stock Scores Rising Relative Strength Upgrade
August 11, 2022
On Thursday, Rocket Pharmaceuticals stock received an upgrade to its Relative Strength (RS) Rating, from 88 to 94.
Via
Investor's Business Daily
Acadia Terminates Painkiller, Cancer Candidate After Disappointing Data
August 09, 2022
Via
Benzinga
Peering Into Vertex Pharmaceuticals Recent Short Interest
August 08, 2022
Vertex Pharmaceuticals' (NASDAQ:VRTX) short percent of float has risen 13.71% since its last report. The company recently reported that it has 3.59 million shares...
Via
Benzinga
Vertex Makes Bullish Move On Earnings, Leading 5 Stocks To Watch
August 06, 2022
Vertex Pharmaceuticals headlines five stocks to watch this week.
Via
Investor's Business Daily
Where Vertex Pharmaceuticals Stands With Analysts
August 05, 2022
Vertex Pharmaceuticals (NASDAQ:VRTX) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Pfizer Is Reportedly In 'Advanced Talks' To Buy Global Blood Therapeutics For $5 Billion
August 05, 2022
Shares of Pfizer's rumored takeover target have rocketed for two days running.
Via
Investor's Business Daily
Vertex Pharma Easily Beats Quarterly Forecasts And Raises 2022 Outlook
August 04, 2022
The company noted it's achieving uptake in regions where Trikafta is now reimbursed.
Via
Investor's Business Daily
ViaCyte Acquisition Can Accelerate Vertex's Ongoing Type 1 Diabetes Programs
July 11, 2022
Via
Benzinga
Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review
August 05, 2022
The Nasdaq and small caps rose while the S&P 500 is hitting resistance.
Via
Investor's Business Daily
$1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth This Much Today
August 05, 2022
Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 10 years by 7.01% on an annualized basis producing an average annual return of 18.39%. Currently, Vertex Pharmaceuticals...
Via
Benzinga
Vertex Pharmaceuticals: Q2 Earnings Insights
August 04, 2022
Vertex Pharmaceuticals (NASDAQ:VRTX) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:01 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
August 04, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Oil Falls Amid Rise In Reserves, China Is Creating A Blockade On Taiwan
August 04, 2022
Crude oil inventories unexpectedly rose by 4.5 million barrels last week, compared to analysts' forecast of 600,000 barrels. The OPEC+ group said it would raise its oil production target by just...
Via
Talk Markets
These 4 Key Sectors Can Be Especially Profitable In A Rising Interest Rate Environment
August 01, 2022
With record inflation, the Federal Reserve has drastically raised interest rates from 0.25% to 1.75% over the course of the year.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
July 28, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Daily Biotech Pulse: VistaGen's Anxiety Study Fails, Silverback To Merge With Firm Developing EpiPen Alternative, Setback For Liminal's Lead Asset
July 22, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
7 Stocks for Beginners to Buy Now
July 22, 2022
Here are seven of the best stocks for beginners to buy now, including BP, Visa and Disney.. They can make excellent long-term investments.
Via
InvestorPlace
Peering Into Vertex Pharmaceuticals's Recent Short Interest
July 21, 2022
Vertex Pharmaceuticals's (NASDAQ:VRTX) short percent of float has fallen 7.46% since its last report. The company recently reported that it has 3.15 million shares sold short,...
Via
Benzinga
Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners
July 21, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
CNBC's Final Trades: Foot Locker, Vertex Pharmaceuticals And This Investment Management Company
July 21, 2022
On CNBC’s “Halftime Report Final Trades,” Bryn Talkington of Requisite Capital Management said her mentor once told her that “one bets against the U.S. at one’s own peril.” She added to this saying,...
Via
Benzinga
Verve Therapeutics, Vertex Join Forces For Liver Disease-Focused Gene Program
July 21, 2022
Via
Benzinga
Goldman Sachs, Costco Get CNBC Fast Money Mentions, With This Stock Jumping 0.66% In Seconds
July 20, 2022
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.
Via
Benzinga
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 15 Years
July 19, 2022
Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 15 years by 9.04% on an annualized basis producing an average annual return of 15.59%. Currently, Vertex Pharmaceuticals...
Via
Benzinga
Crispr Therapeutics Stock Shows Rising Price Performance With Jump To 94 RS Rating
July 15, 2022
Crispr Therapeutics sees its Relative Strength Rating enter the elite 90-plus level.
Via
Investor's Business Daily
Biotech Hasn't Been This Blazing Hot Since Early 2021 — Here Are The Top 5
July 15, 2022
The group has several commonalities, including strong ratings and promising charts.
Via
Investor's Business Daily
Prometheus Biosciences Stock Shows Rising Relative Strength
July 14, 2022
Prometheus Biosciences stock saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, with an increase from 72 to 90.
Via
Investor's Business Daily
Merus Stock Joins Rank Of Stocks With RS Ratings Over 90
July 14, 2022
On Thursday, Netherlands-based Merus stock had its Relative Strength (RS) Rating upgraded to 94 from 78 a day earlier.
Via
Investor's Business Daily
What 8 Analyst Ratings Have To Say About Vertex Pharmaceuticals
July 13, 2022
Analysts have provided the following ratings for Vertex Pharmaceuticals (NASDAQ:VRTX) within the last quarter:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022
July 13, 2022
Upgrades
Via
Benzinga
The 3 Leaders of the Gene Editing Revolution
July 08, 2022
There's a wide field of gene editing stocks, but if you're looking for the best opportunities, there are a few likely winners to watch.
Via
InvestorPlace
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
42
43
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.